4
Tetrahedron Letters
11
Zhang, Z.-H.; Zhang, X.-N.; Mo, L.-P.; Li, Y.-X.; Ma, F.-P.
After reaction completion, the precipitate was separated from the reaction
Green Chem. 2012, 14, 1502.
mixture by filtration and recrystallized from acetone to afford the pure
product. All the products (except 4d, 4p, 4q) are known compounds,
which were identified by IR and 1H NMR spectral data and by
comparison of their melting points with literature reports. N-cyclohexyl-
5-methyl-2-phenyl-imidazo[1,2-a]pyridine-3-amine 4d Light yellow
powder; m.p. 105-108 °C. IR (KBr) cm-1 3285, 2924, 2850, 1550, 1468,
1390. 1H NMR (300 MHz, DMSO-d6) : δ (ppm) 1.02-1.24 (5H, m,
cyclohexyl), 1.46-1.56 (5H, m, cyclohexyl), 2.74 (1H, s, CH), 2.95 (3H,
s, CH3), 3.11 (1H, s, NH), 6.56 (1H, m, H-Ar), 7.20 (1H, m, H-Ar), 7.39-
7.59 (4H, m, H-Ar) 8.13-8.15 (2H, m, H-Ar). 13C NMR (75 MHz,
DMSO-d6) : δ (ppm) 19.9, 24.8, 25.9, 33.1, 58.2, 113.5, 115.6, 124.5,
126.9, 127.4, 127.7, 128.5, 135.5, 136.9, 138.6, 142.7. Anal. Calcd for
C20H23N3: C, 78.65; H, 7.59; N, 13.76; found C, 78.89; H, 7.23; N,13.88.
N-Cyclohexyl-2-(4-Bromophenyl)imidazo[2,1-b]benzothiazol-3-amine
4p Golden powder; m.p. 166-167 °C. IR (KBr) cm-1: 3292, 2927, 2852,
12 Patil, U. B.; Singh, A. S.; Nagarkar, J. M. RSC Adv. 2014, 4, 1102.
13 Rajawat, A.; Khandelwal, S.; Kumar, M. RSC Adv. 2014, 4, 5105.
14 Wang, P.; Ma, F.-P.; Zhang, Z.-H. J. Mol. Liq. 2014, 198, 259.
15 Zhang, Y.; Lü, F.; Cao, X.; Zhao, J. RSC Adv. 2014, 4, 40161.
16 Sanap, A. K.; Shankarling, G. S. RSC Adv. 2014, 4, 34938.
17 Lu, J.; Li, X. T.; Ma, E. Q.; Mo, L. P.; Zhang, Z. H. ChemCatChem 2014,
6, 2854.
18 Assanosi, A. A.; Farah, M. M.; Wood, J.; Al-Duri, B. RSC Adv. 2014, 4,
39359.
19 Azizi, N.; Mariami, M.; Edrisi, M. Dyes Pigm. 2014, 100, 215.
20 Azizi, N.; Dezfooli, S.; Hashemi, M. M. J. Mol. Liq. 2014, 194, 62.
21 Azizi, N.; Yadollahy, Z.; Rahimzadeh-Oskooee, A. Tetrahedron Lett.
2014, 55, 1722.
22 Hu, H.-C.; Liu, Y.-H.; Li, B.-L.; Cui, Z.-S.; Zhang, Z.-H. RSC Adv. 2015,
5, 7720.
1
1589, 1446, 1379, 751. H NMR (300 MHz, DMSO-d6) : δ (ppm) 1.10-
23 Handy, S.; Westbrook, N. M. Tetrahedron Lett. 2014, 55, 4969.
24 Ganem, B. Acc. Chem. Res. 2009, 42, 463.
25 Groebke, K.; Weber, L.; MEHFIN, F. Synlett 1998, 661.
26 Blackburn, C.; Guan, B.; Fleming, P.; Shiosaki, K.; Tsai, S. Tetrahedron
Lett. 1998, 39, 3635.
27 Bienayme, H.; Bouzid, K. Angew. Chem. Int. Ed. 1998, 37, 2234.
28 Devi, N.; Rawal, R. K.; Singh, V. Tetrahedron 2015, 71, 183.
29 Bagdi, A. K.; Santra, S.; Monir, K.; Hajra, A. Chem. Commun. 2015, 51,
1555.
30 Jarami , .; arre er , J. .; e ie , J. .; e Pra , .; am i,
.; n, J. .; n e - ar ne , C. Tetrahedron Lett. 2002, 43,
9051.
31 Rival, Y.; Grassy, G.; Taudou, A.; Ecalle, R. Eur. J. Med. Chem. 1991,
26, 13.
32 Fisher, M. H.; Lusi, A. J. Med. Chem. 1972, 15, 982.
33 Gueiffier, A.; Mavel, S.; Lhassani, M.; Elhakmaoui, A.; Snoeck, R.;
Andrei, G.; Chavignon, O.; Teulade, J.-C.; Witvrouw, M.; Balzarini, J. J.
Med. Chem. 1998, 41, 5108.
1.28 (5H, m, cyclohexyl), 1.63-1.83 (5H, m, cyclohexyl), 2.88 (1H, s,
CH), 3.14 (1H, s, NH), 7.31-7.42 (2H, m, H-Ar), 7.60 (3H, m, H-Ar),
7.99-8.19 (2H, td, Ja = 21.6 and Jb = 6.6 Hz, H-Ar). 13C NMR (75 MHz,
DMSO-d6) : δ (ppm) 24.9, 25.9, 33.5, 53.5, 57.5, 114.3, 119.8, 125.1,
126.8, 128.3, 128.7, 129.6, 130.6, 131.3, 131.6, 131.9, 133.0, 134.2,
136.5, 143.1 Anal. Calcd for C21H20BrN3S: C, 59.16; H, 4.73; N, 9.86;
found C, 59.29 H, 4.89, N, 9.71. 6-Chloro-3-(3-(cyclohexylamino)H-
imidazo[1,2-a]pyridin-2-yl)-4H-chromen- 4-one 4q Orange powder; m.p.
155-158 °C. IR (KBr) cm-1: 3411, 2939, 2854, 1734, 1621, 1543, 1431.
1H NMR (300 MHz, DMSO-d6) : δ (ppm) 1.07 (5H, m, cyclohexyl),
1.46-1.76 (5H, m, cyclohexyl), 2.69 (1H, s, CH), 3.11 (1H, s, NH), 6.90-
6.94 (1H, m, H-Ar), 7.19-7.24 (1H, m, H-Ar), 7.47-7.50 (1H, m, H-Ar),
7.83-7.94 (1H, m, H-Ar), 8.19 (1H, m, H-Ar), 8.96 (1H, s, =CH). 13C
NMR (75 MHz, DMSO-d6) : δ (ppm) 21.3, 24.9, 25.6, 55.9, 112.2, 117.2,
120.3, 121.5, 123.6, 124.4, 124.9, 125.0, 129.1, 130.8, 134.8, 141.4,
154.5, 157.7, 174.9. Anal. Calcd for C22H20ClN3O2: C, 67.09; H, 5.12; N,
10.67; found C, 67.29 H, 4.89, N, 10.96.
54 Kishore, K. G.; Basavanag, U. M.; Islas-Jácome, A.; Gámez-Montaño, R.
Tetrahedron Lett. 2015, 56, 155.
34 Langer, S.; Arbilla, S.; Benavides, J.; Scatton, B. Adv Biochem
Psychopharmacol 1990, 46, 61.
35 Almirante, L.; Polo, L.; Mugnaini, A.; Provinciali, E.; Rugarli, P.;
Biancotti, A.; Gamba, A.; Murmann, W. J. Med. Chem. 1965, 8, 305.
36 Rostamnia, S.; Hassankhani, A. RSC Adv. 2013, 3, 18626.
37 Shinde, A. H.; Srilaxmi, M.; Satpathi, B.; Sharada, D. S. Tetrahedron
Lett. 2014, 55, 5915.
38 Sanaeishoar, T.; Tavakkoli, H.; Mohave, F. Appl. Catal., A 2014, 470, 56.
39 Adib, M.; Mahdavi, M.; Noghani, M. A.; Mirzaei, P. Tetrahedron Lett.
2007, 48, 7263.
40 Guchhait, S. K.; Madaan, C.; Thakkar, B. S. Synthesis 2009, 3293.
41 Guchhait, S. K.; Madaan, C. Synlett 2009, 628.
42 Shaabani, A.; Soleimani, E.; Maleki, A. Tetrahedron Lett. 2006, 47,
3031.
43 Vidyacharan, S.; Shinde, A. H.; Satpathi, B.; Sharada, D. S. Green Chem.
2014, 16, 1168.
44 Shaabani, A.; Keshipour, S.; Shaabani, S.; Mahyari, M. Tetrahedron Lett.
2012, 53, 1641.
45 Shaabani, A.; Rezayan, A. H.; Keshipour, S.; Sarvary, A.; Ng, S. W. Org.
Lett. 2009, 11, 3342.
46 Shaabani, A.; Soleimani, E.; Rezayan, A. H.; Sarvary, A.; Khavasi, H. R.
Org. Lett. 2008, 10, 2581.
47 Shaabani, S.; Shaabani, A.; Ng, S. W. ACS Comb. Sci. 2014, 16, 176.
48 Shaabani, A.; Soleimani, E.; Maleki, A.; Moghimi‐Rad, J. Synth.
Commun. 2008, 38, 1090.
49 Shaabani, A.; Soleimani, E.; Maleki, A. Monatsh. Chem. 2007, 138, 73.
50 Shaabani, A.; Maleki, A.; Moghimi, R. J.; Soleimani, E. Chem. Pharm.
Bull. 2007, 55, 957.
51 Shaabani, A.; Seyyedhamzeh, M.; Shaabani, S.; Ganji, N. Res. Chem.
Intermed., 2015, 41, 2377.
52 Shaabani, A.; Soleimani, E.; Maleki, A.; Moghimi-Rad, J. Mol. Diversity
2009, 13, 269.
53 Preparation of choline chloride-based deep eutectic solvents: Choline
chloride-based deep eutectic solvents were prepared according to the
literature,2-3 and was used without further purification.
Typical procedure for preparation of 3-aminoimidazo-fused
heterocycles: 2-aminopyridine (0.25 mmol), benzaldehyde (0.25 mmol),
and cyclohexyl isocyanide (0.25 mmol) were added to DES (choline
chloride:urea 1 mmol:2 mmol). The resulting mixture was stirred for the
o
specified time (Table 2) at 80 C. After reaction completion, (TLC, ethyl
acetate/n-hexane, 2:1), the reaction mixture was washed with water (10
mL) and the solid residue recrystallized from ethyl acetate to obtain the
pure product. (In the case of imidazo[1,2-a]pyridin-chromones, the
reaction progress was monitored by TLC using CH2Cl2/n-hexane, 1:1).